<?xml
version="1.0" encoding="utf-8"?>
<rss version="2.0" 
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
>

<channel xml:lang="fr">
	<title>Joseph Larmarange</title>
	<link>https://joseph.larmarange.net/</link>
	<description>D&#233;mographe en sant&#233; publique, directeur de recherche HDR &#224; l'IRD,directeur adjoint du Ceped (UMR 196 Universit&#233; Paris Cit&#233;, IRD, Universit&#233; Sorbonne Paris Nord, Inserm)</description>
	<language>fr</language>
	<generator>SPIP - www.spip.net</generator>
	<atom:link href="https://joseph.larmarange.net/spip.php?id_mot=57&amp;page=backend" rel="self" type="application/rss+xml" />

	<image>
		<title>Joseph Larmarange</title>
		<url>https://joseph.larmarange.net/local/cache-vignettes/L144xH52/joseph_larmarange_site-6e82f.svg?1649686173</url>
		<link>https://joseph.larmarange.net/</link>
		<height>52</height>
		<width>144</width>
	</image>



<item xml:lang="fr">
		<title>R&#233;alisation d'une enqu&#234;te t&#233;l&#233;phonique r&#233;p&#233;t&#233;e aupr&#232;s de m&#233;decins burkinab&#233;s en contexte Covid&#160;: retour d'exp&#233;rience de l'enqu&#234;te CAP-CoV-BF</title>
		<link>https://joseph.larmarange.net/sondages-2023</link>
		<guid isPermaLink="true">https://joseph.larmarange.net/sondages-2023</guid>
		<dc:date>2023-03-24T13:00:00Z</dc:date>
		<dc:format>text/html</dc:format>
		<dc:language>fr</dc:language>
		<dc:creator>Joseph LARMARANGE</dc:creator>


		<dc:subject>Burkina Faso</dc:subject>
		<dc:subject>CAP-CoV-Soignants-BF</dc:subject>
		<dc:subject>COVID-19</dc:subject>
		<dc:subject>Enqu&#234;tes par t&#233;l&#233;phone</dc:subject>
		<dc:subject>Repr&#233;sentativit&#233; et Biais</dc:subject>
		<dc:subject>T&#233;l&#233;phones mobiles</dc:subject>
		<dc:subject>Soignants / Professionnels de sant&#233;</dc:subject>

		<description>
&lt;p&gt;Communication orale pr&#233;sent&#233;e le 24&#160;mars 2023 &#224; la 12&lt;sup class=&#034;typo_exposants&#034;&gt;e&lt;/sup&gt; Conf&#233;rence Francophone sur les Sondages. &lt;br class='autobr' /&gt;
Auteurs &lt;br class='autobr' /&gt;
Joseph Larmarange, Arlette Simo Fotso, Yao Abo, D&#233;sir&#233; Dahourou, Z&#233;lie Godin, Kadidiatou Kadio, Apoline Sondo, Louis Valantin, Mathias Altmann, Anne Bekelynck &lt;br class='autobr' /&gt;
R&#233;sum&#233; &lt;br class='autobr' /&gt;
Introduction. Les m&#233;decins, premi&#232;res personnes expos&#233;es et victimes des &#233;pid&#233;mies, sont au c&#339;ur des dispositifs de riposte &#224; l'&#233;pid&#233;mie de Covid-19. Au printemps 2020, au c&#339;ur de la premi&#232;re vague &#233;pid&#233;mique, il est&#160;(&#8230;)&lt;/p&gt;


-
&lt;a href="https://joseph.larmarange.net/-Communications-" rel="directory"&gt;Communications&lt;/a&gt;

/ 
&lt;a href="https://joseph.larmarange.net/+-Burkina-Faso-+" rel="tag"&gt;Burkina Faso&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-CAP-CoV-Soignants-BF-+" rel="tag"&gt;CAP-CoV-Soignants-BF&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-COVID-19-+" rel="tag"&gt;COVID-19&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Enquetes-par-telephone-+" rel="tag"&gt;Enqu&#234;tes par t&#233;l&#233;phone&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Representativite-et-Biais-+" rel="tag"&gt;Repr&#233;sentativit&#233; et Biais&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Telephones-mobiles-+" rel="tag"&gt;T&#233;l&#233;phones mobiles&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-soignants-professionnels-de-sante-+" rel="tag"&gt;Soignants / Professionnels de sant&#233;&lt;/a&gt;

		</description>


 <content:encoded>&lt;img src='https://joseph.larmarange.net/local/cache-vignettes/L150xH100/pexels-photo-4989191-bedff.jpg?1715148298' class='spip_logo spip_logo_right' width='150' height='100' alt=&#034;&#034; /&gt;
		&lt;div class='rss_chapo'&gt;&lt;p&gt;Communication orale pr&#233;sent&#233;e le 24&#160;mars 2023 &#224; la &lt;a href=&#034;https://sondages2023.sciencesconf.org/&#034; class=&#034;spip_out&#034; rel=&#034;external&#034;&gt;12&lt;sup class=&#034;typo_exposants&#034;&gt;e&lt;/sup&gt; Conf&#233;rence Francophone sur les Sondages&lt;/a&gt;.&lt;/p&gt;&lt;/div&gt;
		&lt;div class='rss_texte'&gt;&lt;div class=&#034;hal-resultats&#034;&gt; &lt;div class=&#034;hal-resultat hal-resultat-4043479&#034;&gt; &lt;div class=&#034;hal-thumb&#034;&gt;&lt;a href=&#034;https://ird.hal.science/ird-04043479v1/document&#034; class=&#034;hal-thumb-link&#034;&gt;&lt;img src='https://joseph.larmarange.net/local/cache-vignettes/L75xH43/thumb-92c2e73e-7dbce.png?1702920733' alt=&#034;Image document&#034; width='75' height='43' /&gt; &lt;/a&gt;&lt;/div&gt; &lt;div class=&#034;hal-preview&#034;&gt; &lt;a href=&#034;https://ird.hal.science/ird-04043479v1&#034; class=&#034;hal-titre&#034;&gt; &lt;h3 class=&#034;hal-titre-heading&#034;&gt;R&#233;alisation d'une enqu&#234;te t&#233;l&#233;phonique r&#233;p&#233;t&#233;e aupr&#232;s de m&#233;decins burkinab&#233;s en contexte Covid : retour d'exp&#233;rience de l'enqu&#234;te CAP-CoV-BF&lt;/h3&gt; &lt;/a&gt; &lt;div class=&#034;hal-auteurs&#034;&gt; &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/joseph-larmarange&#034; class=&#034;hal-auteur&#034;&gt;Joseph Larmarange&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/arlette-simo-fotso&#034; class=&#034;hal-auteur&#034;&gt;Arlette Simo Fotso&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Yao+Yabo&#034; class=&#034;hal-auteur&#034;&gt;Yao Yabo&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=742673790998&#034; class=&#034;hal-auteur&#034;&gt;Desire Lucien Dahourou&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Z%C3%A9lie+Godin&#034; class=&#034;hal-auteur&#034;&gt;Z&#233;lie Godin&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Kadidiatou+Kadio&#034; class=&#034;hal-auteur&#034;&gt;Kadidiatou Kadio&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Apoline+Sondo&#034; class=&#034;hal-auteur&#034;&gt;Apoline Sondo&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Louis+Valentin&#034; class=&#034;hal-auteur&#034;&gt;Louis Valentin&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=7426731405548&#034; class=&#034;hal-auteur&#034;&gt;Mathias Altmann&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=7426731007937&#034; class=&#034;hal-auteur&#034;&gt;Anne Bekelynck&lt;/a&gt; &lt;/div&gt; &lt;div class=&#034;hal-citation&#034;&gt;&lt;i&gt;12e Colloque Francophone sur les Sondages&lt;/i&gt;, SFDS; Ined, Mar 2023, Aubervilliers, France&lt;/div&gt; &lt;div class=&#034;hal-typedoc hal-typedoc-comm&#034;&gt;Communication dans un congr&#232;s&lt;/div&gt; &lt;div class=&#034;hal-links&#034;&gt; &lt;a href=&#034;https://ird.hal.science/ird-04043479v1&#034; class=&#034;hal-link hal-link-hal&#034;&gt;ird-04043479&lt;/a&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt;&lt;h2 class=&#034;spip&#034;&gt;
Auteurs&lt;/h2&gt;
&lt;p&gt;Joseph Larmarange, Arlette Simo Fotso, Yao Abo, D&#233;sir&#233; Dahourou, Z&#233;lie Godin, Kadidiatou Kadio, Apoline Sondo, Louis Valantin, Mathias Altmann, Anne Bekelynck&lt;/p&gt;
&lt;h2 class=&#034;spip&#034;&gt;
R&#233;sum&#233;&lt;/h2&gt;
&lt;p&gt;&lt;strong&gt;Introduction.&lt;/strong&gt; Les m&#233;decins, premi&#232;res personnes expos&#233;es et victimes des &#233;pid&#233;mies, sont au c&#339;ur des dispositifs de riposte &#224; l'&#233;pid&#233;mie de Covid-19. Au printemps 2020, au c&#339;ur de la premi&#232;re vague &#233;pid&#233;mique, il est apparu essentiel de pouvoir documenter les connaissances, attitudes et pratiques (CAP) de ces maillons essentiels de la lutte contre la Covid-19 au Burkina Faso. Leur compr&#233;hension de la maladie, l'impact de la maladie sur leurs pratiques professionnelles, leur acc&#232;s au mat&#233;riel de protection, etc. sont autant d'aspects qui peuvent impacter directement la sant&#233; publique, n&#233;cessitant des prises de mesures par les autorit&#233;s nationales. L'objectif principal de cette &#233;tude &#233;tait de fournir aux acteurs nationaux impliqu&#233;s dans la gestion de la crise des donn&#233;es probantes r&#233;guli&#232;res et repr&#233;sentatives &#224; l'&#233;chelle nationale sur les connaissances, attitudes et pratiques des m&#233;decins au Burkina Faso.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;M&#233;thode.&lt;/strong&gt; L'enqu&#234;te CAP-CoV-BF a pu &#234;tre financ&#233;e dans le cadre du programme Aphro-CoV financ&#233; par l'Agence Fran&#231;aise le D&#233;veloppement et mis en &#339;uvre par le consortium REACTing. Le protocole de l'enqu&#234;te a &#233;t&#233; d&#233;velopp&#233; en mai et juin 2020 et soumis au Comit&#233; d'&#201;thique pour la recherche en sant&#233; du Burkina Faso en juin 2020. L'enqu&#234;te a &#233;t&#233; approuv&#233;e fin ao&#251;t. L'enqu&#234;te CAP-CoV-BF est une s&#233;rie de trois vagues d'enqu&#234;tes quantitatives transversales (&#233;chantillons ind&#233;pendants) par t&#233;l&#233;phone r&#233;alis&#233;e aupr&#232;s d'un &#233;chantillon repr&#233;sentatif d'environ 200 m&#233;decins sur l'ensemble du territoire burkinab&#232;. Les trois vagues ont &#233;t&#233; r&#233;alis&#233;es &#224; diff&#233;rents stades de l'&#233;pid&#233;mie burkinab&#233;&#160;: (i) alors que le nombre de cas &#233;tait relativement peu important et plut&#244;t stable en septembre 2020&lt;small class=&#034;fine d-inline&#034;&gt;&#160;&lt;/small&gt;; (ii) d&#233;but d&#233;cembre 2020 alors que le pays faisait face au d&#233;but d'un nouveau pic &#233;pid&#233;mique&lt;small class=&#034;fine d-inline&#034;&gt;&#160;&lt;/small&gt;; (iii) fin f&#233;vrier 2021 &#224; la fin de la vague &#233;pid&#233;mique ayant d&#233;marr&#233; en d&#233;cembre 2020. La base d'&#233;chantillonnage &#233;tait l'annuaire de l'ordre national des m&#233;decins du Burkina Faso (3548 m&#233;decins enregistr&#233;s).&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;R&#233;sultats.&lt;/strong&gt; Avant chaque vague d'enqu&#234;te, 750 m&#233;decins &#233;taient tir&#233;s au sort et recevaient un SMS de pr&#233;annonce de l'enqu&#234;te. Ils avaient la possibilit&#233; &#224; cette &#233;tape de r&#233;pondre au SMS pour refuser d'&#234;tre appel&#233; (vague 1&#160;: 0 refus, vague 2&#160;: 7, vague 3&#160;: 9). L'envoi du SMS permettait &#233;galement de v&#233;rifier si les num&#233;ros &#233;taient toujours valides. Parmi les num&#233;ros valides et sans refus, un second &#233;chantillonnage &#233;tait effectu&#233;. Chaque num&#233;ro de t&#233;l&#233;phone mis en production &#233;tait rappel&#233; au moins 5 fois (5 jours &#224; des horaires diff&#233;rents) avant d'&#234;tre consid&#233;r&#233; comme injoignable. Les refus de participer apr&#232;s d&#233;crochage sont rest&#233;s relativement limit&#233;s (respectivement 23, 5 et 10). Au final, 166 questionnaires ont &#233;t&#233; compl&#233;t&#233; en 15 jours de collecte lors de la premi&#232;re enqu&#234;te, 190 questionnaires en 13 jours pour la seconde et 203 questionnaires en 13 jours pour la troisi&#232;me.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Conclusion.&lt;/strong&gt; Le dispositif d'enqu&#234;te a permis de r&#233;aliser en des temps courts et avec un budget limit&#233; une enqu&#234;te nationale et repr&#233;sentative des m&#233;decins au Burkina Faso. La passation par t&#233;l&#233;phone a permis &#224; la fois de couvrir l'ensemble du territoire national tout en respectant les proc&#233;dures de distanciations en vigueur.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Mots-cl&#233;s.&lt;/strong&gt; Burkina Faso, enqu&#234;te par t&#233;l&#233;phone, m&#233;decins, Covid 19, enqu&#234;te CAP&lt;/p&gt;&lt;/div&gt;
		
		</content:encoded>


		
		<enclosure url="https://joseph.larmarange.net/IMG/pdf/larmarange_et_al._-_sondages_2023_-_resume_long.pdf" length="868719" type="application/pdf" />
		
		<enclosure url="https://joseph.larmarange.net/IMG/pdf/larmarange_et_al._-_sondages_2023_-_diaporama.pdf" length="2658051" type="application/pdf" />
		

	</item>
<item xml:lang="fr">
		<title>D&#233;crire les &#233;pid&#233;mies, Comprendre les populations&#160;: une d&#233;mographie du VIH en Afrique subsaharienne</title>
		<link>https://joseph.larmarange.net/hdr</link>
		<guid isPermaLink="true">https://joseph.larmarange.net/hdr</guid>
		<dc:date>2022-10-14T06:38:12Z</dc:date>
		<dc:format>text/html</dc:format>
		<dc:language>fr</dc:language>
		<dc:creator>Joseph LARMARANGE</dc:creator>


		<dc:subject>Afrique subsaharienne</dc:subject>
		<dc:subject>ATLAS</dc:subject>
		<dc:subject>CAP-CoV-Soignants-BF</dc:subject>
		<dc:subject>DOD-CI (ANRS 12287 / 12323)</dc:subject>
		<dc:subject>ELIHoS (ANRS 12139)</dc:subject>
		<dc:subject>PrEP CI (ANRS 12361)</dc:subject>
		<dc:subject>Pr&#233;valences du VIH (ANRS 12114)</dc:subject>
		<dc:subject>prevR</dc:subject>
		<dc:subject>PRINCESSE</dc:subject>
		<dc:subject>TasP (ANRS 12249)</dc:subject>
		<dc:subject>Afrique du Sud</dc:subject>
		<dc:subject>Burkina Faso</dc:subject>
		<dc:subject>C&#244;te d'Ivoire</dc:subject>
		<dc:subject>Mali</dc:subject>
		<dc:subject>S&#233;n&#233;gal</dc:subject>
		<dc:subject>Acc&#232;s aux soins</dc:subject>
		<dc:subject>Analyse de s&#233;quences</dc:subject>
		<dc:subject>Approches biographiques</dc:subject>
		<dc:subject>Approches communautaires</dc:subject>
		<dc:subject>Autotests VIH</dc:subject>
		<dc:subject>Cartographie</dc:subject>
		<dc:subject>Cascade des soins</dc:subject>
		<dc:subject>Comparaison de cohortes</dc:subject>
		<dc:subject>Comportements sexuels</dc:subject>
		<dc:subject>D&#233;mographie</dc:subject>
		<dc:subject>D&#233;pistage</dc:subject>
		<dc:subject>EDS (Enqu&#234;tes D&#233;mographiques et de Sant&#233;)</dc:subject>
		<dc:subject>Enqu&#234;tes par t&#233;l&#233;phone</dc:subject>
		<dc:subject>Enseignement acad&#233;mique</dc:subject>
		<dc:subject>Lien vers les soins</dc:subject>
		<dc:subject>&#201;pid&#233;miologie</dc:subject>
		<dc:subject>Essais cliniques</dc:subject>
		<dc:subject>Estimateurs &#224; noyau (kernel density estimation)</dc:subject>
		<dc:subject>Femmes enceintes</dc:subject>
		<dc:subject>Financement des programmes</dc:subject>
		<dc:subject>H&#233;patites virales</dc:subject>
		<dc:subject>Homo / Bisexualit&#233;s</dc:subject>
		<dc:subject>Identit&#233;s sexuelles</dc:subject>
		<dc:subject>Incidence du VIH</dc:subject>
		<dc:subject>Interpolation spatiale</dc:subject>
		<dc:subject>IST (Infections Sexuellement Transmissibles)</dc:subject>
		<dc:subject>Itin&#233;raires th&#233;rapeutiques</dc:subject>
		<dc:subject>Masculinit&#233;s</dc:subject>
		<dc:subject>M&#233;nages</dc:subject>
		<dc:subject>Mesure d'impact</dc:subject>
		<dc:subject>Mesure des indicateurs</dc:subject>
		<dc:subject>M&#233;thodologie</dc:subject>
		<dc:subject>Migrations</dc:subject>
		<dc:subject>Observatoire de population</dc:subject>
		<dc:subject>Partenaires sexuel(le)s</dc:subject>
		<dc:subject>PrEP</dc:subject>
		<dc:subject>Pr&#233;valence du VIH</dc:subject>
		<dc:subject>Pr&#233;vention</dc:subject>
		<dc:subject>Prise en charge</dc:subject>
		<dc:subject>Recherche interventionnelle</dc:subject>
		<dc:subject>Recherche participative/communautaire</dc:subject>
		<dc:subject>Recrutement &#171;&lt;small class=&#034;fine d-inline&#034;&gt;&#160;&lt;/small&gt;boules de neige&lt;small class=&#034;fine d-inline&#034;&gt;&#160;&lt;/small&gt;&#187;</dc:subject>
		<dc:subject>Repr&#233;sentations / Perceptions</dc:subject>
		<dc:subject>Repr&#233;sentativit&#233; et Biais</dc:subject>
		<dc:subject>Sant&#233; publique</dc:subject>
		<dc:subject>Sant&#233; sexuelle</dc:subject>
		<dc:subject>Structure des populations</dc:subject>
		<dc:subject>Structures de sant&#233;</dc:subject>
		<dc:subject>Surveillance sentinelle</dc:subject>
		<dc:subject>T&#233;l&#233;phones mobiles</dc:subject>
		<dc:subject>Temporalit&#233;s</dc:subject>
		<dc:subject>Traitement antir&#233;troviral (ARV)</dc:subject>
		<dc:subject>Travail du sexe</dc:subject>
		<dc:subject>Treatment as Prevention (TasP)</dc:subject>
		<dc:subject>Universal Test &amp; Treat (UTT)</dc:subject>
		<dc:subject>Usager&lt;span aria-hidden='true'&gt;&#183;&lt;/span&gt;e&lt;span aria-hidden='true'&gt;&#183;&lt;/span&gt;s de drogue</dc:subject>
		<dc:subject>VIH / SIDA</dc:subject>

		<description>
&lt;p&gt;Habilitation &#224; Diriger des Recherches soutenue le 12&#160;octobre 2012 par Joseph Larmarange &#224; l'Universit&#233; Paris Cit&#233;. &lt;br class='autobr' /&gt; D&#233;crire les &#233;pid&#233;mies, Comprendre les populations&#160;: une d&#233;mographie du VIH en Afrique subsaharienne &lt;br class='autobr' /&gt; Joseph Larmarange D&#233;mographie. Universit&#233; Paris Cit&#233;, 2022 HDR tel-03814024&lt;/p&gt;


-
&lt;a href="https://joseph.larmarange.net/-Publications-11-" rel="directory"&gt;Publications&lt;/a&gt;

/ 
&lt;a href="https://joseph.larmarange.net/+-Afrique-subsaharienne-+" rel="tag"&gt;Afrique subsaharienne&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-ATLAS-+" rel="tag"&gt;ATLAS&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-CAP-CoV-Soignants-BF-+" rel="tag"&gt;CAP-CoV-Soignants-BF&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-DOD-CI-ANRS-12287-+" rel="tag"&gt;DOD-CI (ANRS 12287 / 12323)&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-ELIHoS-ANRS-12139-+" rel="tag"&gt;ELIHoS (ANRS 12139)&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-PrEP-CI-ANRS-12361-+" rel="tag"&gt;PrEP CI (ANRS 12361)&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Prevalences-du-VIH-ANRS-12114-+" rel="tag"&gt;Pr&#233;valences du VIH (ANRS 12114)&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-prevR-+" rel="tag"&gt;prevR&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-PRINCESSE-+" rel="tag"&gt;PRINCESSE&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-TasP-ANRS-12249-97-+" rel="tag"&gt;TasP (ANRS 12249)&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Afrique-du-Sud-+" rel="tag"&gt;Afrique du Sud&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Burkina-Faso-+" rel="tag"&gt;Burkina Faso&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Cote-d-Ivoire-+" rel="tag"&gt;C&#244;te d'Ivoire&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Mali-+" rel="tag"&gt;Mali&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Senegal-+" rel="tag"&gt;S&#233;n&#233;gal&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Acces-aux-soins-+" rel="tag"&gt;Acc&#232;s aux soins&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Analyse-de-sequences-+" rel="tag"&gt;Analyse de s&#233;quences&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Approches-biographiques-+" rel="tag"&gt;Approches biographiques&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Approches-communautaires-+" rel="tag"&gt;Approches communautaires&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Autotests-VIH-+" rel="tag"&gt;Autotests VIH&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Cartographie-+" rel="tag"&gt;Cartographie&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Cascade-des-soins-+" rel="tag"&gt;Cascade des soins&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Comparaison-de-cohortes-+" rel="tag"&gt;Comparaison de cohortes&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Comportements-sexuels-+" rel="tag"&gt;Comportements sexuels&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Demographie-+" rel="tag"&gt;D&#233;mographie&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Depistage-+" rel="tag"&gt;D&#233;pistage&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-EDS-Enquetes-Demographiques-et-de-+" rel="tag"&gt;EDS (Enqu&#234;tes D&#233;mographiques et de Sant&#233;)&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Enquetes-par-telephone-+" rel="tag"&gt;Enqu&#234;tes par t&#233;l&#233;phone&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Enseignement-academique-+" rel="tag"&gt;Enseignement acad&#233;mique&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Entree-en-soins-+" rel="tag"&gt;Lien vers les soins&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Epidemiologie-+" rel="tag"&gt;&#201;pid&#233;miologie&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Essais-cliniques-+" rel="tag"&gt;Essais cliniques&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Estimateurs-a-noyau-kernel-density-+" rel="tag"&gt;Estimateurs &#224; noyau (kernel density estimation)&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Femmes-enceintes-+" rel="tag"&gt;Femmes enceintes&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Financement-des-programmes-+" rel="tag"&gt;Financement des programmes&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Hepatites-virales-+" rel="tag"&gt;H&#233;patites virales&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-MSM-Homo-Bisexualite-+" rel="tag"&gt;Homo / Bisexualit&#233;s&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Identites-sexuelles-+" rel="tag"&gt;Identit&#233;s sexuelles&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Incidence-du-VIH-+" rel="tag"&gt;Incidence du VIH&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Interpolation-spatiale-+" rel="tag"&gt;Interpolation spatiale&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-IST-Infections-Sexuellement-+" rel="tag"&gt;IST (Infections Sexuellement Transmissibles)&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Itineraires-therapeutiques-+" rel="tag"&gt;Itin&#233;raires th&#233;rapeutiques&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Masculinites-+" rel="tag"&gt;Masculinit&#233;s&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Menages-+" rel="tag"&gt;M&#233;nages&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Mesure-d-impact-+" rel="tag"&gt;Mesure d'impact&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Validite-de-la-mesure-+" rel="tag"&gt;Mesure des indicateurs&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Methodologie-+" rel="tag"&gt;M&#233;thodologie&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Migrations-+" rel="tag"&gt;Migrations&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Observatoire-de-population-+" rel="tag"&gt;Observatoire de population&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Partenaires-sexuel-le-s-+" rel="tag"&gt;Partenaires sexuel(le)s&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-PrEP-+" rel="tag"&gt;PrEP&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Prevalence-du-VIH-+" rel="tag"&gt;Pr&#233;valence du VIH&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Prevention-+" rel="tag"&gt;Pr&#233;vention&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Prise-en-charge-+" rel="tag"&gt;Prise en charge&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Recherche-interventionnelle-+" rel="tag"&gt;Recherche interventionnelle&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Recherche-participative-+" rel="tag"&gt;Recherche participative/communautaire&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Recrutement-boules-de-neige-+" rel="tag"&gt;Recrutement &#171;&lt;small class=&#034;fine d-inline&#034;&gt;&#160;&lt;/small&gt;boules de neige&lt;small class=&#034;fine d-inline&#034;&gt;&#160;&lt;/small&gt;&#187;&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Representations-Perceptions-+" rel="tag"&gt;Repr&#233;sentations / Perceptions&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Representativite-et-Biais-+" rel="tag"&gt;Repr&#233;sentativit&#233; et Biais&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Sante-publique-+" rel="tag"&gt;Sant&#233; publique&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Sante-sexuelle-+" rel="tag"&gt;Sant&#233; sexuelle&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Structure-des-populations-+" rel="tag"&gt;Structure des populations&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Structures-de-sante-+" rel="tag"&gt;Structures de sant&#233;&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Surveillance-sentinelle-+" rel="tag"&gt;Surveillance sentinelle&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Telephones-mobiles-+" rel="tag"&gt;T&#233;l&#233;phones mobiles&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Temporalites-142-+" rel="tag"&gt;Temporalit&#233;s&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Traitement-antiretroviral-ARV-98-98-+" rel="tag"&gt;Traitement antir&#233;troviral (ARV)&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Travail-du-sexe-+" rel="tag"&gt;Travail du sexe&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Treatment-as-Prevention-TasP-105-+" rel="tag"&gt;Treatment as Prevention (TasP)&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Universal-Test-Treat-UTT-+" rel="tag"&gt;Universal Test &amp; Treat (UTT)&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Usagers-de-drogue-par-voie-+" rel="tag"&gt;Usager&lt;span aria-hidden='true'&gt;&#183;&lt;/span&gt;e&lt;span aria-hidden='true'&gt;&#183;&lt;/span&gt;s de drogue&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-VIH-SIDA-+" rel="tag"&gt;VIH / SIDA&lt;/a&gt;

		</description>


 <content:encoded>&lt;img src='https://joseph.larmarange.net/local/cache-vignettes/L150xH109/ruban_spirales-a3fec.png?1715097926' class='spip_logo spip_logo_right' width='150' height='109' alt=&#034;&#034; /&gt;
		&lt;div class='rss_chapo'&gt;&lt;p&gt;Habilitation &#224; Diriger des Recherches soutenue le 12&#160;octobre 2012 par Joseph Larmarange &#224; l'Universit&#233; Paris Cit&#233;.&lt;/p&gt;&lt;/div&gt;
		&lt;div class='rss_texte'&gt;&lt;div class=&#034;hal-resultats&#034;&gt; &lt;div class=&#034;hal-resultat hal-resultat-3814024&#034;&gt; &lt;div class=&#034;hal-thumb&#034;&gt;&lt;a href=&#034;https://theses.hal.science/tel-03814024v1/document&#034; class=&#034;hal-thumb-link&#034;&gt;&lt;img src='https://joseph.larmarange.net/local/cache-vignettes/L53xH75/thumb-877a2ad2-17cac.png?1702907846' alt=&#034;Image document&#034; width='53' height='75' /&gt; &lt;/a&gt;&lt;/div&gt; &lt;div class=&#034;hal-preview&#034;&gt; &lt;a href=&#034;https://theses.hal.science/tel-03814024v1&#034; class=&#034;hal-titre&#034;&gt; &lt;h3 class=&#034;hal-titre-heading&#034;&gt;D&#233;crire les &#233;pid&#233;mies, Comprendre les populations : une d&#233;mographie du VIH en Afrique subsaharienne&lt;/h3&gt; &lt;/a&gt; &lt;div class=&#034;hal-auteurs&#034;&gt; &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/joseph-larmarange&#034; class=&#034;hal-auteur&#034;&gt;Joseph Larmarange&lt;/a&gt; &lt;/div&gt; &lt;div class=&#034;hal-citation&#034;&gt;D&#233;mographie. Universit&#233; Paris Cit&#233;, 2022&lt;/div&gt; &lt;div class=&#034;hal-typedoc hal-typedoc-hdr&#034;&gt;HDR&lt;/div&gt; &lt;div class=&#034;hal-links&#034;&gt; &lt;a href=&#034;https://theses.hal.science/tel-03814024v1&#034; class=&#034;hal-link hal-link-hal&#034;&gt;tel-03814024&lt;/a&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt;&lt;iframe width=&#034;100%&#034; height=&#034;500&#034; src=&#034;https://www.youtube.com/embed/me6rDSq0p0k&#034; title=&#034;YouTube video player&#034; frameborder=&#034;0&#034; allow=&#034;accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture&#034; allowfullscreen&gt;&lt;/iframe&gt;&lt;h2 class=&#034;spip&#034;&gt;
Jury&lt;/h2&gt;&lt;ul class=&#034;spip&#034; role=&#034;list&#034;&gt;&lt;li&gt; Didier Breton (Universit&#233; de Strasbourg, rapporteur)&lt;/li&gt;&lt;li&gt; Val&#233;rie Delauney (IRD, rapportrice)&lt;/li&gt;&lt;li&gt; Annabel Desgr&#233;es du Lo&#251; (IRD, garante)&lt;/li&gt;&lt;li&gt; G&#233;raldine Duth&#233; (Ined, rapportrice)&lt;/li&gt;&lt;li&gt; Didier Ekouevi (Inserm, Universit&#233; de Lom&#233;, examinateur)&lt;/li&gt;&lt;li&gt; V&#233;ronique Petit (Universit&#233; Paris Cit&#233;, pr&#233;sidente)&lt;/li&gt;&lt;/ul&gt;&lt;/div&gt;
		
		</content:encoded>


		
		<enclosure url="https://joseph.larmarange.net/IMG/pdf/hdr_larmarange_v2022-10-12.pdf" length="15224200" type="application/pdf" />
		

	</item>
<item xml:lang="en">
		<title>Is it possible to recruit HIV self-test users for an anonymous phone-based survey using passive recruitment without financial incentives? Lessons learned from a pilot study in C&#244;te d'Ivoire</title>
		<link>https://joseph.larmarange.net/Is-it-possible-to-recruit-HIV-self</link>
		<guid isPermaLink="true">https://joseph.larmarange.net/Is-it-possible-to-recruit-HIV-self</guid>
		<dc:date>2022-01-10T13:25:26Z</dc:date>
		<dc:format>text/html</dc:format>
		<dc:language>en</dc:language>
		<dc:creator>Joseph LARMARANGE</dc:creator>


		<dc:subject>C&#244;te d'Ivoire</dc:subject>
		<dc:subject>ATLAS</dc:subject>
		<dc:subject>Autotests VIH</dc:subject>
		<dc:subject>D&#233;pistage</dc:subject>
		<dc:subject>Mesure d'impact</dc:subject>
		<dc:subject>M&#233;thodologie</dc:subject>
		<dc:subject>Repr&#233;sentativit&#233; et Biais</dc:subject>
		<dc:subject>T&#233;l&#233;phones mobiles</dc:subject>
		<dc:subject>VIH / SIDA</dc:subject>
		<dc:subject>Enqu&#234;tes par t&#233;l&#233;phone</dc:subject>

		<description>
&lt;p&gt;Authors &lt;br class='autobr' /&gt;
Arlette Simo Fotso, Ars&#232;ne Kouassi Kra, Mathieu Maheu-Giroux, Sokhna Boye, Marc d'Elb&#233;e, Odette Ky-zerbo, Nicolas Rouveau, Noel Kouassi N'Guessan, Olivier Geoffroy, Anthony Vautier &amp; Joseph Larmarange for the ATLAS Team &lt;br class='autobr' /&gt;
Abstract &lt;br class='autobr' /&gt;
Background &lt;br class='autobr' /&gt;
Due to the discreet and private nature of HIV self-testing (HIVST), it is particularly challenging to monitor and assess the impacts of this testing strategy. To overcome this challenge, we conducted a study in C&#244;te d'Ivoire to&#160;(&#8230;)&lt;/p&gt;


-
&lt;a href="https://joseph.larmarange.net/-Publications-11-" rel="directory"&gt;Publications&lt;/a&gt;

/ 
&lt;a href="https://joseph.larmarange.net/+-Cote-d-Ivoire-+" rel="tag"&gt;C&#244;te d'Ivoire&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-ATLAS-+" rel="tag"&gt;ATLAS&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Autotests-VIH-+" rel="tag"&gt;Autotests VIH&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Depistage-+" rel="tag"&gt;D&#233;pistage&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Mesure-d-impact-+" rel="tag"&gt;Mesure d'impact&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Methodologie-+" rel="tag"&gt;M&#233;thodologie&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Representativite-et-Biais-+" rel="tag"&gt;Repr&#233;sentativit&#233; et Biais&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Telephones-mobiles-+" rel="tag"&gt;T&#233;l&#233;phones mobiles&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-VIH-SIDA-+" rel="tag"&gt;VIH / SIDA&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Enquetes-par-telephone-+" rel="tag"&gt;Enqu&#234;tes par t&#233;l&#233;phone&lt;/a&gt;

		</description>


 <content:encoded>&lt;img src='https://joseph.larmarange.net/local/cache-vignettes/L150xH100/arton308-87a0d.jpg?1715148299' class='spip_logo spip_logo_right' width='150' height='100' alt=&#034;&#034; /&gt;
		&lt;div class='rss_texte'&gt;&lt;div class=&#034;hal-resultats&#034;&gt; &lt;div class=&#034;hal-resultat hal-resultat-3880490&#034;&gt; &lt;div class=&#034;hal-thumb&#034;&gt;&lt;a href=&#034;https://ird.hal.science/ird-03719921v1/document&#034; class=&#034;hal-thumb-link&#034;&gt;&lt;img src='https://joseph.larmarange.net/local/cache-vignettes/L57xH75/thumb-9fae92fb-22d3b.png?1702907847' alt=&#034;Image document&#034; width='57' height='75' /&gt; &lt;/a&gt;&lt;/div&gt; &lt;div class=&#034;hal-preview&#034;&gt; &lt;a href=&#034;https://ird.hal.science/ird-03719921v1&#034; class=&#034;hal-titre&#034;&gt; &lt;h3 class=&#034;hal-titre-heading&#034;&gt;Is it possible to recruit HIV self-test users for an anonymous phone-based survey using passive recruitment without financial incentives? Lessons learned from a pilot study in C&#244;te d'Ivoire&lt;/h3&gt; &lt;/a&gt; &lt;div class=&#034;hal-auteurs&#034;&gt; &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/arlette-simo-fotso&#034; class=&#034;hal-auteur&#034;&gt;Arlette Simo Fotso&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/kra-djuhe-kouassi&#034; class=&#034;hal-auteur&#034;&gt;Arsene Kra Kouassi&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Mathieu+Maheu-Giroux&#034; class=&#034;hal-auteur&#034;&gt;Mathieu Maheu-Giroux&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Sokhna+Boye&#034; class=&#034;hal-auteur&#034;&gt;Sokhna Boye&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Marc+d%27Elbee&#034; class=&#034;hal-auteur&#034;&gt;Marc d'Elbee&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=742673782050&#034; class=&#034;hal-auteur&#034;&gt;Odette Ky-Zerbo&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Nicolas+Rouveau&#034; class=&#034;hal-auteur&#034;&gt;Nicolas Rouveau&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Noel+Kouassi+N%27Guessan&#034; class=&#034;hal-auteur&#034;&gt;Noel Kouassi N'Guessan&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Olivier+Geoffroy&#034; class=&#034;hal-auteur&#034;&gt;Olivier Geoffroy&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Anthony+Vautier&#034; class=&#034;hal-auteur&#034;&gt;Anthony Vautier&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/joseph-larmarange&#034; class=&#034;hal-auteur&#034;&gt;Joseph Larmarange&lt;/a&gt; &lt;/div&gt; &lt;div class=&#034;hal-citation&#034;&gt;&lt;i&gt;Pilot and Feasibility Studies&lt;/i&gt;, 2022, Pilot and Feasibility Studies, 8 (1), pp.4. &lt;a target=&#034;_blank&#034; href=&#034;https://dx.doi.org/10.1186/s40814-021-00965-2&#034; rel=&#034;noreferrer noopener&#034;&gt;&#10216;10.1186/s40814-021-00965-2&#10217;&lt;/a&gt;&lt;/div&gt; &lt;div class=&#034;hal-typedoc hal-typedoc-art&#034;&gt;Article dans une revue&lt;/div&gt; &lt;div class=&#034;hal-links&#034;&gt; &lt;a href=&#034;https://ird.hal.science/ird-03719921v1&#034; class=&#034;hal-link hal-link-hal&#034;&gt;ird-03719921&lt;/a&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt;&lt;h2 class=&#034;spip&#034;&gt;
Authors&lt;/h2&gt;
&lt;p&gt;Arlette Simo Fotso, Ars&#232;ne Kouassi Kra, Mathieu Maheu-Giroux, Sokhna Boye, Marc d'Elb&#233;e, Odette Ky-zerbo, Nicolas Rouveau, Noel Kouassi N'Guessan, Olivier Geoffroy, Anthony Vautier &amp; Joseph Larmarange for the ATLAS Team&lt;/p&gt;
&lt;h2 class=&#034;spip&#034;&gt;
Abstract&lt;/h2&gt;
&lt;p&gt;&lt;strong&gt;Background&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;Due to the discreet and private nature of HIV self-testing (HIVST), it is particularly challenging to monitor and assess the impacts of this testing strategy. To overcome this challenge, we conducted a study in C&#244;te d'Ivoire to characterize the profile of end users of HIVST kits distributed through the ATLAS project (AutoTest VIH, Libre d'Acc&#233;der &#224; la connaissance de son Statut). Feasibility was assessed using a pilot phone-based survey.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Methods&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;The ATLAS project aims to distribute 221300 HIVST kits in C&#244;te d'Ivoire from 2019 to 2021 through both primary (e.g., direct distribution to primary users) and secondary distribution (e.g., for partner testing). The pilot survey used a passive recruitment strategy&#8212;whereby participants voluntarily called a toll-free survey phone number&#8212;to enrol participants. The survey was promoted through a sticker on the HIVST instruction leaflet and hotline invitations and informal promotion by HIVST kit-dispensing agents. Importantly, participation was not financially incentivized, even though surveys focussed on key populations usually use incentives in this context.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Results&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;After a 7-month period in which 25,000 HIVST kits were distributed, only 42 questionnaires were completed. Nevertheless, the survey collected data from users receiving HIVST kits via both primary and secondary distribution (69% and 31%, respectively).&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Conclusion&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;This paper provides guidance on how to improve the design of future surveys of this type. It discusses the need to financial incentivize participation, to reorganize the questionnaire, the importance of better informing and training stakeholders involved in the distribution of HIVST, and the use of flyers to increase the enrolment of users reached through secondary distribution.&lt;/p&gt;&lt;/div&gt;
		
		</content:encoded>


		

	</item>
<item xml:lang="fr">
		<title>Au-del&#224; des populations cl&#233;s&#160;: la distribution secondaire de kits d'autod&#233;pistage du VIH en Afrique de l'Ouest</title>
		<link>https://joseph.larmarange.net/Au-dela-des-populations-cles-la</link>
		<guid isPermaLink="true">https://joseph.larmarange.net/Au-dela-des-populations-cles-la</guid>
		<dc:date>2021-12-09T18:42:00Z</dc:date>
		<dc:format>text/html</dc:format>
		<dc:language>fr</dc:language>
		<dc:creator>Joseph LARMARANGE</dc:creator>


		<dc:subject>C&#244;te d'Ivoire</dc:subject>
		<dc:subject>Mali</dc:subject>
		<dc:subject>S&#233;n&#233;gal</dc:subject>
		<dc:subject>ATLAS</dc:subject>
		<dc:subject>Approches communautaires</dc:subject>
		<dc:subject>Autotests VIH</dc:subject>
		<dc:subject>Co&#251;ts</dc:subject>
		<dc:subject>D&#233;pistage</dc:subject>
		<dc:subject>Mesure d'impact</dc:subject>
		<dc:subject>Mesure des indicateurs</dc:subject>
		<dc:subject>Mod&#233;lisation</dc:subject>
		<dc:subject>Homo / Bisexualit&#233;s</dc:subject>
		<dc:subject>Recherche interventionnelle</dc:subject>
		<dc:subject>Recherche participative/communautaire</dc:subject>
		<dc:subject>Repr&#233;sentativit&#233; et Biais</dc:subject>
		<dc:subject>Ressources &#233;conomiques</dc:subject>
		<dc:subject>Sant&#233; publique</dc:subject>
		<dc:subject>T&#233;l&#233;phones mobiles</dc:subject>
		<dc:subject>Travail du sexe</dc:subject>
		<dc:subject>VIH / SIDA</dc:subject>

		<description>
&lt;p&gt;Communication orale dans le cadre du symposium ATLAS qui s'est tenu le 7&#160;d&#233;cembre 2021 dans le cadre de la 21&lt;sup class=&#034;typo_exposants&#034;&gt;e&lt;/sup&gt; conf&#233;rence ICASA. &lt;br class='autobr' /&gt; Au-del&#224; des populations cl&#233;s&#160;: la distribution secondaire de kits d'autod&#233;pistage du VIH en Afrique de l'Ouest &lt;br class='autobr' /&gt; Joseph Larmarange 21th ICASA (International Conference on AIDS and STIs in Africa), Society for AIDS in Africa (SAA), Dec 2021, Durban,&#160;(&#8230;)&lt;/p&gt;


-
&lt;a href="https://joseph.larmarange.net/-Communications-" rel="directory"&gt;Communications&lt;/a&gt;

/ 
&lt;a href="https://joseph.larmarange.net/+-Cote-d-Ivoire-+" rel="tag"&gt;C&#244;te d'Ivoire&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Mali-+" rel="tag"&gt;Mali&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Senegal-+" rel="tag"&gt;S&#233;n&#233;gal&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-ATLAS-+" rel="tag"&gt;ATLAS&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Approches-communautaires-+" rel="tag"&gt;Approches communautaires&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Autotests-VIH-+" rel="tag"&gt;Autotests VIH&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Couts-+" rel="tag"&gt;Co&#251;ts&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Depistage-+" rel="tag"&gt;D&#233;pistage&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Mesure-d-impact-+" rel="tag"&gt;Mesure d'impact&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Validite-de-la-mesure-+" rel="tag"&gt;Mesure des indicateurs&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Modelisation-+" rel="tag"&gt;Mod&#233;lisation&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-MSM-Homo-Bisexualite-+" rel="tag"&gt;Homo / Bisexualit&#233;s&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Recherche-interventionnelle-+" rel="tag"&gt;Recherche interventionnelle&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Recherche-participative-+" rel="tag"&gt;Recherche participative/communautaire&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Representativite-et-Biais-+" rel="tag"&gt;Repr&#233;sentativit&#233; et Biais&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Ressources-economiques-+" rel="tag"&gt;Ressources &#233;conomiques&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Sante-publique-+" rel="tag"&gt;Sant&#233; publique&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Telephones-mobiles-+" rel="tag"&gt;T&#233;l&#233;phones mobiles&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Travail-du-sexe-+" rel="tag"&gt;Travail du sexe&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-VIH-SIDA-+" rel="tag"&gt;VIH / SIDA&lt;/a&gt;

		</description>


 <content:encoded>&lt;img src='https://joseph.larmarange.net/local/cache-vignettes/L150xH100/arton303-bb012.jpg?1715124947' class='spip_logo spip_logo_right' width='150' height='100' alt=&#034;&#034; /&gt;
		&lt;div class='rss_chapo'&gt;&lt;p&gt;Communication orale dans le cadre du &lt;i&gt;symposium ATLAS&lt;/i&gt; qui s'est tenu le 7&#160;d&#233;cembre 2021 dans le cadre de la 21&lt;sup class=&#034;typo_exposants&#034;&gt;e&lt;/sup&gt; conf&#233;rence ICASA.&lt;/p&gt;&lt;/div&gt;
		&lt;div class='rss_texte'&gt;&lt;div class=&#034;hal-resultats&#034;&gt; &lt;div class=&#034;hal-resultat hal-resultat-4058389&#034;&gt; &lt;div class=&#034;hal-thumb&#034;&gt;&lt;a href=&#034;https://ird.hal.science/ird-04058389v1/document&#034; class=&#034;hal-thumb-link&#034;&gt;&lt;img src='https://joseph.larmarange.net/local/cache-vignettes/L75xH56/thumb-8366f2e5-18527.png?1702942077' alt=&#034;Image document&#034; width='75' height='56' /&gt; &lt;/a&gt;&lt;/div&gt; &lt;div class=&#034;hal-preview&#034;&gt; &lt;a href=&#034;https://ird.hal.science/ird-04058389v1&#034; class=&#034;hal-titre&#034;&gt; &lt;h3 class=&#034;hal-titre-heading&#034;&gt;Au-del&#224; des populations cl&#233;s : la distribution secondaire de kits d'autod&#233;pistage du VIH en Afrique de l'Ouest&lt;/h3&gt; &lt;/a&gt; &lt;div class=&#034;hal-auteurs&#034;&gt; &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/joseph-larmarange&#034; class=&#034;hal-auteur&#034;&gt;Joseph Larmarange&lt;/a&gt; &lt;/div&gt; &lt;div class=&#034;hal-citation&#034;&gt;&lt;i&gt;21th ICASA (International Conference on AIDS and STIs in Africa)&lt;/i&gt;, Society for AIDS in Africa (SAA), Dec 2021, Durban, Afrique du Sud&lt;/div&gt; &lt;div class=&#034;hal-typedoc hal-typedoc-comm&#034;&gt;Communication dans un congr&#232;s&lt;/div&gt; &lt;div class=&#034;hal-links&#034;&gt; &lt;a href=&#034;https://ird.hal.science/ird-04058389v1&#034; class=&#034;hal-link hal-link-hal&#034;&gt;ird-04058389&lt;/a&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt;&lt;iframe width=&#034;100%&#034; height=&#034;450&#034; src=&#034;https://www.youtube-nocookie.com/embed/QTqyNkIIjK0?start=594&#034; title=&#034;YouTube video player&#034; frameborder=&#034;0&#034; allow=&#034;accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture&#034; allowfullscreen&gt;&lt;/iframe&gt;&lt;/div&gt;
		
		</content:encoded>


		

	</item>
<item xml:lang="en">
		<title>Telephone peer recruitment and interviewing during a respondent-driven sampling (RDS) survey: feasibility and field experience from the first phone-based RDS survey among men who have sex with men in C&#244;te d'Ivoire</title>
		<link>https://joseph.larmarange.net/Telephone-peer-recruitment-and</link>
		<guid isPermaLink="true">https://joseph.larmarange.net/Telephone-peer-recruitment-and</guid>
		<dc:date>2021-02-08T15:26:04Z</dc:date>
		<dc:format>text/html</dc:format>
		<dc:language>en</dc:language>
		<dc:creator>Joseph LARMARANGE</dc:creator>


		<dc:subject>C&#244;te d'Ivoire</dc:subject>
		<dc:subject>DOD-CI (ANRS 12287 / 12323)</dc:subject>
		<dc:subject>D&#233;pistage</dc:subject>
		<dc:subject>Identit&#233;s sexuelles</dc:subject>
		<dc:subject>M&#233;thodologie</dc:subject>
		<dc:subject>Homo / Bisexualit&#233;s</dc:subject>
		<dc:subject>Recrutement &#171; boules de neige &#187;</dc:subject>
		<dc:subject>Repr&#233;sentativit&#233; et Biais</dc:subject>
		<dc:subject>VIH / SIDA</dc:subject>

		<description>
&lt;p&gt;Authors &lt;br class='autobr' /&gt;
Maxime Inghels, Ars&#232;ne Kra Kouassi, Serge Niangoran, Anne Bekelynck, S&#233;verine Carillon, Lazare Sika, Mariatou Kon&#233;, Christine Danel, Annabel Desgr&#233;es du Lo&#251; &amp; Joseph Larmarange for the research team ANRS 12323 DOD-CI &lt;br class='autobr' /&gt;
Abstract &lt;br class='autobr' /&gt;
Background &lt;br class='autobr' /&gt;
Many respondent-driven sampling (RDS) methodologies have been employed to investigate hard-to-reach populations; however, these methodologies present some limits. We describe a minimally investigated RDS methodology in which peer&#160;(&#8230;)&lt;/p&gt;


-
&lt;a href="https://joseph.larmarange.net/-Publications-11-" rel="directory"&gt;Publications&lt;/a&gt;

/ 
&lt;a href="https://joseph.larmarange.net/+-Cote-d-Ivoire-+" rel="tag"&gt;C&#244;te d'Ivoire&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-DOD-CI-ANRS-12287-+" rel="tag"&gt;DOD-CI (ANRS 12287 / 12323)&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Depistage-+" rel="tag"&gt;D&#233;pistage&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Identites-sexuelles-+" rel="tag"&gt;Identit&#233;s sexuelles&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Methodologie-+" rel="tag"&gt;M&#233;thodologie&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-MSM-Homo-Bisexualite-+" rel="tag"&gt;Homo / Bisexualit&#233;s&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Recrutement-boules-de-neige-+" rel="tag"&gt;Recrutement &#171; boules de neige &#187;&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Representativite-et-Biais-+" rel="tag"&gt;Repr&#233;sentativit&#233; et Biais&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-VIH-SIDA-+" rel="tag"&gt;VIH / SIDA&lt;/a&gt;

		</description>


 <content:encoded>&lt;img src='https://joseph.larmarange.net/local/cache-vignettes/L150xH100/arton289-5ee0d.jpg?1715132649' class='spip_logo spip_logo_right' width='150' height='100' alt=&#034;&#034; /&gt;
		&lt;div class='rss_texte'&gt;&lt;div class=&#034;hal-resultats&#034;&gt; &lt;div class=&#034;hal-resultat hal-resultat-3188848&#034;&gt; &lt;div class=&#034;hal-thumb&#034;&gt;&lt;a href=&#034;https://hal.science/hal-03188848v1/document&#034; class=&#034;hal-thumb-link&#034;&gt;&lt;img src='https://joseph.larmarange.net/local/cache-vignettes/L57xH75/thumb-379df592-0295d.png?1702912391' alt=&#034;Image document&#034; width='57' height='75' /&gt; &lt;/a&gt;&lt;/div&gt; &lt;div class=&#034;hal-preview&#034;&gt; &lt;a href=&#034;https://hal.science/hal-03188848v1&#034; class=&#034;hal-titre&#034;&gt; &lt;h3 class=&#034;hal-titre-heading&#034;&gt;Telephone peer recruitment and interviewing during a respondent-driven sampling (RDS) survey: feasibility and field experience from the first phone-based RDS survey among men who have sex with men in C&#244;te d'Ivoire&lt;/h3&gt; &lt;/a&gt; &lt;div class=&#034;hal-auteurs&#034;&gt; &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Maxime+Inghels&#034; class=&#034;hal-auteur&#034;&gt;Maxime Inghels&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/kra-djuhe-kouassi&#034; class=&#034;hal-auteur&#034;&gt;Arsene Kra Kouassi&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Serge+Niangoran&#034; class=&#034;hal-auteur&#034;&gt;Serge Niangoran&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Anne+Bekelynck&#034; class=&#034;hal-auteur&#034;&gt;Anne Bekelynck&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Severine+Carillon&#034; class=&#034;hal-auteur&#034;&gt;Severine Carillon&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Lazare+Sika&#034; class=&#034;hal-auteur&#034;&gt;Lazare Sika&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Mariatou+Kone&#034; class=&#034;hal-auteur&#034;&gt;Mariatou Kone&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Christine+Danel&#034; class=&#034;hal-auteur&#034;&gt;Christine Danel&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/annabel-desgrees-du-lou&#034; class=&#034;hal-auteur&#034;&gt;Annabel Desgr&#233;es du Lo&#251;&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/joseph-larmarange&#034; class=&#034;hal-auteur&#034;&gt;Joseph Larmarange&lt;/a&gt; &lt;/div&gt; &lt;div class=&#034;hal-citation&#034;&gt;&lt;i&gt;BMC Medical Research Methodology&lt;/i&gt;, 2021, 21 (1), pp.25. &lt;a target=&#034;_blank&#034; href=&#034;https://dx.doi.org/10.1186/s12874-021-01208-x&#034; rel=&#034;noreferrer noopener&#034;&gt;&#10216;10.1186/s12874-021-01208-x&#10217;&lt;/a&gt;&lt;/div&gt; &lt;div class=&#034;hal-typedoc hal-typedoc-art&#034;&gt;Article dans une revue&lt;/div&gt; &lt;div class=&#034;hal-links&#034;&gt; &lt;a href=&#034;https://hal.science/hal-03188848v1&#034; class=&#034;hal-link hal-link-hal&#034;&gt;hal-03188848&lt;/a&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt;&lt;h2 class=&#034;spip&#034;&gt;
Authors&lt;/h2&gt;
&lt;p&gt;Maxime Inghels, Ars&#232;ne Kra Kouassi, Serge Niangoran, Anne Bekelynck, S&#233;verine Carillon, Lazare Sika, Mariatou Kon&#233;, Christine Danel, Annabel Desgr&#233;es du Lo&#251; &amp; Joseph Larmarange for the research team ANRS 12323 DOD-CI&lt;/p&gt;
&lt;h2 class=&#034;spip&#034;&gt;
Abstract&lt;/h2&gt;
&lt;p&gt;&lt;strong&gt;Background&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;Many respondent-driven sampling (RDS) methodologies have been employed to investigate hard-to-reach populations; however, these methodologies present some limits. We describe a minimally investigated RDS methodology in which peer recruitment and interviewing are phone-based. The feasibility of the methodology, field experiences, validity of RDS assumptions and characteristics of the sample obtained are discussed.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Methods&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;We conducted a phone-based RDS survey among men who have sex with men (MSM) aged 18 or above and living in C&#244;te d'Ivoire. Eight initial MSM across C&#244;te d'Ivoire were selected. Participants were asked to call a hotline to be registered and interviewed by phone. After the participants completed the questionnaire, they were asked to recruit a maximum of 3 MSM from their acquaintances.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Results&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;During the 9 months of the survey, 576 individuals called the hotline, and 518 MSM completed the questionnaire. The median delay between the invitation to participate and the completion of the questionnaire by peer-recruited MSM was 4&#8201;days [IQR: 1&#8211;12]. The recruitment process was not constant, with high variation in the number of people who called the hotline during the survey period.&lt;/p&gt;
&lt;p&gt;RDS chain convergence to equilibrium was reached within 6 waves for most of the selected variables. For the network size estimation assumption, participants who incorrectly estimated their network size were observed.&lt;/p&gt;
&lt;p&gt;Regarding the sample obtained, MSM were recruited from all the regions of C&#244;te d'Ivoire with frequent interregional recruitment; 23.5% of MSM were recruited by someone who does not live in the same region. Compared to the MSM who participated in two other surveys in C&#244;te d'Ivoire, the MSM in our sample were less likely to know about an MSM non-governmental organisation. However, MSM aged 30&#8201;years old and above and those with a low level of education were underrepresented in our sample.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Conclusion&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;We show that phone-based RDS surveys among MSM are feasible in the context of sub-Saharan Africa. Compared to other classical RDS survey methodologies, the phone-based RDS methodology seems to reduce selection bias based on geography and proximity with the MSM community. However, similar to other methodologies, phone-based RDS fails to reach older and less-educated MSM.&lt;/p&gt;&lt;/div&gt;
		
		</content:encoded>


		

	</item>
<item xml:lang="fr">
		<title>Un m&#234;me objet biographique sous l'angle de plusieurs approches m&#233;thodologiques</title>
		<link>https://joseph.larmarange.net/un-meme-objet-biographique-sous-l</link>
		<guid isPermaLink="true">https://joseph.larmarange.net/un-meme-objet-biographique-sous-l</guid>
		<dc:date>2018-10-19T14:03:53Z</dc:date>
		<dc:format>text/html</dc:format>
		<dc:language>fr</dc:language>
		<dc:creator>Joseph LARMARANGE</dc:creator>


		<dc:subject>M&#233;thodologie</dc:subject>
		<dc:subject>Mesure des indicateurs</dc:subject>
		<dc:subject>Acc&#232;s aux soins</dc:subject>
		<dc:subject>Repr&#233;sentativit&#233; et Biais</dc:subject>
		<dc:subject>R&#233;gression logistique</dc:subject>
		<dc:subject>D&#233;mographie</dc:subject>
		<dc:subject>Programmation / Code</dc:subject>
		<dc:subject>Analyse de s&#233;quences</dc:subject>
		<dc:subject>Classification hi&#233;rarchique</dc:subject>
		<dc:subject>Cascade des soins</dc:subject>
		<dc:subject>Approches biographiques</dc:subject>

		<description>
&lt;p&gt;Communication orale pr&#233;sent&#233;e le 18&#160;octobre 2018 &#224; Paris dans le cadre du colloque Parcours de vie et sant&#233;&#160;: apports des m&#233;thodes biographiques en sant&#233; publique. &lt;br class='autobr' /&gt; L'ensemble des analyses et le code correspondant est disponible sur http://larmarange.github.io/analyse-R/trajectoires-de-soins.html R&#233;f&#233;rence &lt;br class='autobr' /&gt;
Larmarange Joseph (2018) &#171;&lt;small class=&#034;fine d-inline&#034;&gt;&#160;&lt;/small&gt;Un m&#234;me objet biographique sous l'angle de plusieurs approches m&#233;thodologiques&lt;small class=&#034;fine d-inline&#034;&gt;&#160;&lt;/small&gt;&#187; (communication orale), pr&#233;sent&#233; &#224; Parcours de vie et sant&#233;&#160;: apports des&#160;(&#8230;)&lt;/p&gt;


-
&lt;a href="https://joseph.larmarange.net/-Communications-" rel="directory"&gt;Communications&lt;/a&gt;

/ 
&lt;a href="https://joseph.larmarange.net/+-Methodologie-+" rel="tag"&gt;M&#233;thodologie&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Validite-de-la-mesure-+" rel="tag"&gt;Mesure des indicateurs&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Acces-aux-soins-+" rel="tag"&gt;Acc&#232;s aux soins&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Representativite-et-Biais-+" rel="tag"&gt;Repr&#233;sentativit&#233; et Biais&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Regression-logistique-+" rel="tag"&gt;R&#233;gression logistique&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Demographie-+" rel="tag"&gt;D&#233;mographie&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-programmation-code-+" rel="tag"&gt;Programmation / Code&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Analyse-de-sequences-+" rel="tag"&gt;Analyse de s&#233;quences&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Classification-hierarchique-+" rel="tag"&gt;Classification hi&#233;rarchique&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Cascade-des-soins-+" rel="tag"&gt;Cascade des soins&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Approches-biographiques-+" rel="tag"&gt;Approches biographiques&lt;/a&gt;

		</description>


 <content:encoded>&lt;img src='https://joseph.larmarange.net/local/cache-vignettes/L150xH100/arton241-cadd5.jpg?1715127904' class='spip_logo spip_logo_right' width='150' height='100' alt=&#034;&#034; /&gt;
		&lt;div class='rss_chapo'&gt;&lt;p&gt;Communication orale pr&#233;sent&#233;e le 18&#160;octobre 2018 &#224; Paris dans le cadre du colloque &lt;i&gt;Parcours de vie et sant&#233;&#160;: apports des m&#233;thodes biographiques en sant&#233; publique&lt;/i&gt;.&lt;/p&gt;&lt;/div&gt;
		&lt;div class='rss_texte'&gt;&lt;p&gt;L'ensemble des analyses et le code correspondant est disponible sur &lt;a href=&#034;http://larmarange.github.io/analyse-R/trajectoires-de-soins.html&#034; class=&#034;spip_url spip_out auto&#034; rel=&#034;nofollow external&#034;&gt;http://larmarange.github.io/analyse-R/trajectoires-de-soins.html&lt;/a&gt;&lt;/p&gt;
&lt;iframe width=&#034;100%&#034; height=&#034;450&#034; src=&#034;https://www.youtube.com/embed/SCaiB3YCC2U&#034; frameborder=&#034;0&#034; allow=&#034;accelerometer; autoplay; encrypted-media; gyroscope; picture-in-picture&#034; allowfullscreen&gt;&lt;/iframe&gt;&lt;h2 class=&#034;spip&#034;&gt;
R&#233;f&#233;rence&lt;/h2&gt;
&lt;p&gt;&lt;abbr class=&#034;unapi-id&#034; title=&#034;F7I4FJY3&#034;&gt;&lt;/abbr&gt;&lt;span class=&#034;csl-bib-body&#034;&gt;&lt;span class=&#034;csl-entry&#034;&gt;&lt;span style=&#034;font-variant: small-caps;&#034;&gt;Larmarange&lt;/span&gt; Joseph (2018) &#171;&#160;Un m&#234;me objet biographique sous l'angle de plusieurs approches m&#233;thodologiques&#160;&#187; (communication orale), pr&#233;sent&#233; &#224; &lt;span style=&#034;font-style: italic;&#034; &gt;Parcours de vie et sant&#233; : apports des m&#233;thodes biographiques en sant&#233; publique&lt;/span&gt;, Paris. https://biographiesante2018.sciencesconf.org/.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;
		
		</content:encoded>


		
		<enclosure url="https://joseph.larmarange.net/IMG/pdf/larmarange_biographiesante2018.pdf" length="1315651" type="application/pdf" />
		

	</item>
<item xml:lang="fr">
		<title>The impact of population dynamics on the population HIV care cascade&#160;: results from the ANRS 12249 Treatment as Prevention trial in rural KwaZulu&#8208;Natal (South Africa)</title>
		<link>https://joseph.larmarange.net/The-impact-of-population-dynamics</link>
		<guid isPermaLink="true">https://joseph.larmarange.net/The-impact-of-population-dynamics</guid>
		<dc:date>2018-07-20T06:54:03Z</dc:date>
		<dc:format>text/html</dc:format>
		<dc:language>fr</dc:language>
		<dc:creator>Joseph LARMARANGE</dc:creator>


		<dc:subject>VIH / SIDA</dc:subject>
		<dc:subject>Mesure des indicateurs</dc:subject>
		<dc:subject>Migrations</dc:subject>
		<dc:subject>Structure des populations</dc:subject>
		<dc:subject>Repr&#233;sentativit&#233; et Biais</dc:subject>
		<dc:subject>Afrique du Sud</dc:subject>
		<dc:subject>Mesure d'impact</dc:subject>
		<dc:subject>TasP (ANRS 12249)</dc:subject>
		<dc:subject>Treatment as Prevention (TasP)</dc:subject>
		<dc:subject>Cascade des soins</dc:subject>
		<dc:subject>Universal Test &amp; Treat (UTT)</dc:subject>

		<description>
&lt;p&gt;Authors &lt;br class='autobr' /&gt;
Joseph Larmarange, Mamadou Hassimiou Diallo, Nuala McGrath, Collins Iwuji, M&#233;lanie Plazy, Rodolphe Thi&#233;baut, Frank Tanser, Till B&#228;rnighausen, Deenan Pillay, Fran&#231;ois Dabis, Joanna Orne&#8208;Gliemann for the ANRS 12249 TasP Study Group &lt;br class='autobr' /&gt;
Abstract &lt;br class='autobr' /&gt;
Introduction &lt;br class='autobr' /&gt;
The universal test and treat strategy (UTT) was developed to maximize the proportion of all HIV&#8208;positive individuals on antiretroviral treatment (ART) and virally suppressed, assuming that it will lead to a reduction in HIV&#160;(&#8230;)&lt;/p&gt;


-
&lt;a href="https://joseph.larmarange.net/-Publications-11-" rel="directory"&gt;Publications&lt;/a&gt;

/ 
&lt;a href="https://joseph.larmarange.net/+-VIH-SIDA-+" rel="tag"&gt;VIH / SIDA&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Validite-de-la-mesure-+" rel="tag"&gt;Mesure des indicateurs&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Migrations-+" rel="tag"&gt;Migrations&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Structure-des-populations-+" rel="tag"&gt;Structure des populations&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Representativite-et-Biais-+" rel="tag"&gt;Repr&#233;sentativit&#233; et Biais&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Afrique-du-Sud-+" rel="tag"&gt;Afrique du Sud&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Mesure-d-impact-+" rel="tag"&gt;Mesure d'impact&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-TasP-ANRS-12249-97-+" rel="tag"&gt;TasP (ANRS 12249)&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Treatment-as-Prevention-TasP-105-+" rel="tag"&gt;Treatment as Prevention (TasP)&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Cascade-des-soins-+" rel="tag"&gt;Cascade des soins&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Universal-Test-Treat-UTT-+" rel="tag"&gt;Universal Test &amp; Treat (UTT)&lt;/a&gt;

		</description>


 <content:encoded>&lt;img src='https://joseph.larmarange.net/local/cache-vignettes/L150xH112/arton236-1ee78.png?1715161566' class='spip_logo spip_logo_right' width='150' height='112' alt=&#034;&#034; /&gt;
		&lt;div class='rss_texte'&gt;&lt;h2 class=&#034;spip&#034;&gt;
Authors&lt;/h2&gt;
&lt;p&gt;Joseph Larmarange, Mamadou Hassimiou Diallo, Nuala McGrath, Collins Iwuji, M&#233;lanie Plazy, Rodolphe Thi&#233;baut, Frank Tanser, Till B&#228;rnighausen, Deenan Pillay, Fran&#231;ois Dabis, Joanna Orne&#8208;Gliemann for the ANRS 12249 TasP Study Group&lt;/p&gt;
&lt;h2 class=&#034;spip&#034;&gt;
Abstract&lt;/h2&gt;
&lt;p&gt;&lt;strong&gt;Introduction&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;The universal test and treat strategy (UTT) was developed to maximize the proportion of all HIV&#8208;positive individuals on antiretroviral treatment (ART) and virally suppressed, assuming that it will lead to a reduction in HIV incidence at the population level. The evolution over time of the cross&#8208;sectional HIV care cascade is determined by individual longitudinal trajectories through the HIV care continuum and underlying population dynamics. The purpose of this paper is to quantify the contribution of each component of population change (in&#8208; and out&#8208;migration, HIV seroconversion, ageing into the cohort and definitive exit such as death) on the HIV care cascade in the context of the ANRS 12249 Treatment as Prevention (TasP) cluster&#8208;randomized trial, investigating UTT in rural KwaZulu&#8208;Natal, South Africa, between 2012 and 2016.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Methods&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;HIV test results and information on clinic visits, ART prescriptions, viral load and CD4 count, migration and deaths were used to calculate residency status, HIV status and HIV care status for each individual on a daily basis. Position within the HIV care continuum was considered as a score ranging from 0 (undiagnosed) to 4 (virally suppressed). We compared the cascade score of each individual joining or leaving the population of resident adults living with HIV with the average score of their cluster at the time of entry or exit. Then, we computed the contribution of each entry or exit on the average cascade score and their annualized total contribution, by component of change.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Results&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;While the average cascade score increased over time in all clusters, that increase was constrained by population dynamics. Permanent exits and ageing into the people living with HIV cohort had a marginal effect. Both in&#8208;migrants and out&#8208;migrants were less likely to be retained at each step of the HIV care continuum. However, their overall impact on the cross&#8208;sectional cascade was limited as the effect of in&#8208; and out&#8208;migration balanced each other. The contribution of HIV seroconversions was negative in all clusters.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Conclusions&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;In a context of high HIV incidence, the continuous flow of newly infected individuals slows down the efforts to increase ART coverage and population viral suppression, ultimately attenuating any population&#8208;level impact on HIV incidence.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Clinical Trial Number&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;NCT01509508 (clinicalTrials.gov)/DOH&#8208;27&#8208;0512&#8208;3974 (South African National Clinical Trials Register).&lt;/p&gt;
&lt;h2 class=&#034;spip&#034;&gt;
Reference&lt;/h2&gt;
&lt;p&gt;&lt;abbr class=&#034;unapi-id&#034; title=&#034;DQRJ52CL&#034;&gt;&lt;/abbr&gt;&lt;span class=&#034;csl-bib-body&#034;&gt;&lt;span class=&#034;csl-entry&#034;&gt;&lt;span style=&#034;font-variant: small-caps;&#034;&gt;Larmarange&lt;/span&gt; Joseph, &lt;span style=&#034;font-variant: small-caps;&#034;&gt;Diallo&lt;/span&gt; Mamadou Hassimiou, &lt;span style=&#034;font-variant: small-caps;&#034;&gt;McGrath&lt;/span&gt; Nuala, &lt;span style=&#034;font-variant: small-caps;&#034;&gt;Iwuji&lt;/span&gt; Collins, &lt;span style=&#034;font-variant: small-caps;&#034;&gt;Plazy&lt;/span&gt; M&#233;lanie, &lt;span style=&#034;font-variant: small-caps;&#034;&gt;Thi&#233;baut&lt;/span&gt; Rodolphe, &lt;span style=&#034;font-variant: small-caps;&#034;&gt;Tanser&lt;/span&gt; Frank, &lt;span style=&#034;font-variant: small-caps;&#034;&gt;B&#228;rnighausen&lt;/span&gt; Till, &lt;span style=&#034;font-variant: small-caps;&#034;&gt;Pillay&lt;/span&gt; Deenan, &lt;span style=&#034;font-variant: small-caps;&#034;&gt;Dabis&lt;/span&gt; Fran&#231;ois et &lt;span style=&#034;font-variant: small-caps;&#034;&gt;Orne-Gliemann&lt;/span&gt; Joanna (2018) &#171;&#160;The impact of population dynamics on the population HIV care cascade: results from the ANRS 12249 Treatment as Prevention trial in rural KwaZulu-Natal (South Africa)&#160;&#187;, &lt;span style=&#034;font-style: italic;&#034; &gt;Journal of the International AIDS Society&lt;/span&gt;, 21 (S4) (juillet 20), p.&#160;e25128. DOI&#160;: 10.1002/jia2.25128. https://onlinelibrary.wiley.com/doi/abs/10.1002/jia2.25128.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;
		
		</content:encoded>


		

	</item>
<item xml:lang="fr">
		<title>Continuum homobisexuel, cat&#233;gories d'enqu&#234;tes et exposition au VIH en Afrique sub-saharienne</title>
		<link>https://joseph.larmarange.net/continuum-homobisexuel-categories</link>
		<guid isPermaLink="true">https://joseph.larmarange.net/continuum-homobisexuel-categories</guid>
		<dc:date>2018-07-07T10:47:20Z</dc:date>
		<dc:format>text/html</dc:format>
		<dc:language>fr</dc:language>
		<dc:creator>Joseph LARMARANGE</dc:creator>


		<dc:subject>VIH / SIDA</dc:subject>
		<dc:subject>Homo / Bisexualit&#233;s</dc:subject>
		<dc:subject>Pr&#233;valence du VIH</dc:subject>
		<dc:subject>Mesure des indicateurs</dc:subject>
		<dc:subject>Afrique subsaharienne</dc:subject>
		<dc:subject>Identit&#233;s sexuelles</dc:subject>
		<dc:subject>Recrutement &#171;&lt;small class=&#034;fine d-inline&#034;&gt;&#160;&lt;/small&gt;boules de neige&lt;small class=&#034;fine d-inline&#034;&gt;&#160;&lt;/small&gt;&#187;</dc:subject>
		<dc:subject>Relations de genre</dc:subject>
		<dc:subject>Repr&#233;sentativit&#233; et Biais</dc:subject>
		<dc:subject>Partenaires sexuel(le)s</dc:subject>

		<description>
&lt;p&gt;Communication orale pr&#233;sent&#233;e &#224; la Journ&#233;e d'&#233;tude Minorit&#233;s de Genre et de Sexualit&#233;&#160;: objectivation, cat&#233;gorisations et pratiques d'enqu&#234;tes organis&#233;e par l'Ined le 3&#160;juillet 2018 &#224; Paris. Auteurs &lt;br class='autobr' /&gt;
Joseph Larmarange et Christophe Broque R&#233;f&#233;rence &lt;br class='autobr' /&gt;
Larmarange Joseph et Broqua Christophe (2018) &#171;&lt;small class=&#034;fine d-inline&#034;&gt;&#160;&lt;/small&gt;Continuum homobisexuel, cat&#233;gories d'enqu&#234;tes et exposition au VIH en Afrique sub-saharienne&lt;small class=&#034;fine d-inline&#034;&gt;&#160;&lt;/small&gt;&#187; (communication orale), pr&#233;sent&#233; &#224; Journ&#233;e d'&#233;tude Minorit&#233;s de Genre et de Sexualit&#233;&#160;:&#160;(&#8230;)&lt;/p&gt;


-
&lt;a href="https://joseph.larmarange.net/-Communications-" rel="directory"&gt;Communications&lt;/a&gt;

/ 
&lt;a href="https://joseph.larmarange.net/+-VIH-SIDA-+" rel="tag"&gt;VIH / SIDA&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-MSM-Homo-Bisexualite-+" rel="tag"&gt;Homo / Bisexualit&#233;s&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Prevalence-du-VIH-+" rel="tag"&gt;Pr&#233;valence du VIH&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Validite-de-la-mesure-+" rel="tag"&gt;Mesure des indicateurs&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Afrique-subsaharienne-+" rel="tag"&gt;Afrique subsaharienne&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Identites-sexuelles-+" rel="tag"&gt;Identit&#233;s sexuelles&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Recrutement-boules-de-neige-+" rel="tag"&gt;Recrutement &#171;&lt;small class=&#034;fine d-inline&#034;&gt;&#160;&lt;/small&gt;boules de neige&lt;small class=&#034;fine d-inline&#034;&gt;&#160;&lt;/small&gt;&#187;&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Relations-de-genre-+" rel="tag"&gt;Relations de genre&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Representativite-et-Biais-+" rel="tag"&gt;Repr&#233;sentativit&#233; et Biais&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Partenaires-sexuel-le-s-+" rel="tag"&gt;Partenaires sexuel(le)s&lt;/a&gt;

		</description>


 <content:encoded>&lt;img src='https://joseph.larmarange.net/local/cache-vignettes/L150xH82/arton233-a963d.png?1715107021' class='spip_logo spip_logo_right' width='150' height='82' alt=&#034;&#034; /&gt;
		&lt;div class='rss_texte'&gt;&lt;p&gt;Communication orale pr&#233;sent&#233;e &#224; la Journ&#233;e d'&#233;tude &lt;a href=&#034;https://www.ined.fr/fr/actualites/rencontres-scientifiques/seminaires-colloques-ined/journee-etude-minorites-de-genre-et-de-sexualite/&#034; class=&#034;spip_out&#034; rel=&#034;external&#034;&gt;Minorit&#233;s de Genre et de Sexualit&#233;&#160;: objectivation, cat&#233;gorisations et pratiques d'enqu&#234;tes&lt;/a&gt; organis&#233;e par l'Ined le 3&#160;juillet 2018 &#224; Paris.&lt;/p&gt;
&lt;h2 class=&#034;spip&#034;&gt;
Auteurs&lt;/h2&gt;
&lt;p&gt;Joseph Larmarange et Christophe Broque&lt;/p&gt;
&lt;h2 class=&#034;spip&#034;&gt;
R&#233;f&#233;rence&lt;/h2&gt;
&lt;p&gt;&lt;abbr class=&#034;unapi-id&#034; title=&#034;3UF2M4FY&#034;&gt;&lt;/abbr&gt;&lt;span class=&#034;csl-bib-body&#034;&gt;&lt;span class=&#034;csl-entry&#034;&gt;&lt;span style=&#034;font-variant: small-caps;&#034;&gt;Larmarange&lt;/span&gt; Joseph et &lt;span style=&#034;font-variant: small-caps;&#034;&gt;Broqua&lt;/span&gt; Christophe (2018) &#171;&#160;Continuum homobisexuel, cat&#233;gories d'enqu&#234;tes et exposition au VIH en Afrique sub-saharienne&#160;&#187; (communication orale), pr&#233;sent&#233; &#224; &lt;span style=&#034;font-style: italic;&#034; &gt;Journ&#233;e d'&#233;tude Minorit&#233;s de Genre et de Sexualit&#233; : objectivation, cat&#233;gorisations et pratiques d'enqu&#234;tes&lt;/span&gt;, Paris. https://www.ined.fr/fr/actualites/rencontres-scientifiques/seminaires-colloques-ined/journee-etude-minorites-de-genre-et-de-sexualite/.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;
		
		</content:encoded>


		
		<enclosure url="https://joseph.larmarange.net/IMG/pdf/larmarange_broqua_ined_3_juillet_2018.pdf" length="1714472" type="application/pdf" />
		

	</item>
<item xml:lang="fr">
		<title>D&#233;pister, traiter les populations cach&#233;es</title>
		<link>https://joseph.larmarange.net/Depister-traiter-les-populations</link>
		<guid isPermaLink="true">https://joseph.larmarange.net/Depister-traiter-les-populations</guid>
		<dc:date>2018-04-08T16:16:43Z</dc:date>
		<dc:format>text/html</dc:format>
		<dc:language>fr</dc:language>
		<dc:creator>Joseph LARMARANGE</dc:creator>


		<dc:subject>VIH / SIDA</dc:subject>
		<dc:subject>Homo / Bisexualit&#233;s</dc:subject>
		<dc:subject>Pr&#233;vention</dc:subject>
		<dc:subject>Afrique subsaharienne</dc:subject>
		<dc:subject>Identit&#233;s sexuelles</dc:subject>
		<dc:subject>Recrutement &#171;&lt;small class=&#034;fine d-inline&#034;&gt;&#160;&lt;/small&gt;boules de neige&lt;small class=&#034;fine d-inline&#034;&gt;&#160;&lt;/small&gt;&#187;</dc:subject>
		<dc:subject>Acc&#232;s aux soins</dc:subject>
		<dc:subject>Repr&#233;sentativit&#233; et Biais</dc:subject>
		<dc:subject>&#201;pid&#233;miologie</dc:subject>
		<dc:subject>Traitement antir&#233;troviral (ARV)</dc:subject>
		<dc:subject>D&#233;pistage</dc:subject>
		<dc:subject>Prise en charge</dc:subject>
		<dc:subject>Travail du sexe</dc:subject>
		<dc:subject>Treatment as Prevention (TasP)</dc:subject>

		<description>
&lt;p&gt;Communication orale pr&#233;sent&#233;e en session pl&#233;ni&#232;re le 5&#160;avril 2018 lors de la 9&lt;sup class=&#034;typo_exposants&#034;&gt;e&lt;/sup&gt; conf&#233;rence francophone sur le VIH et les h&#233;patites virales &#224; Bordeaux. Auteur &lt;br class='autobr' /&gt;
Joseph Larmarange Vid&#233;o Pr&#233;sentation Pl&#233;ni&#232;re AFRAVIH 2018 (Joseph Larmarange)3.1&#160;Mio R&#233;f&#233;rence &lt;br class='autobr' /&gt;
Larmarange Joseph (2018) &#171;&lt;small class=&#034;fine d-inline&#034;&gt;&#160;&lt;/small&gt;D&#233;pister, traiter les populations cach&#233;es&lt;small class=&#034;fine d-inline&#034;&gt;&#160;&lt;/small&gt;&#187; (communication orale en session pl&#233;ni&#232;re), pr&#233;sent&#233; &#224; 9&lt;sup class=&#034;typo_exposants&#034;&gt;e&lt;/sup&gt; Conf&#233;rence Internationale Francophone sur le VIH et les H&#233;patites Virales (AFRAVIH 2018), Bordeaux.&#160;(&#8230;)&lt;/p&gt;


-
&lt;a href="https://joseph.larmarange.net/-Communications-" rel="directory"&gt;Communications&lt;/a&gt;

/ 
&lt;a href="https://joseph.larmarange.net/+-VIH-SIDA-+" rel="tag"&gt;VIH / SIDA&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-MSM-Homo-Bisexualite-+" rel="tag"&gt;Homo / Bisexualit&#233;s&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Prevention-+" rel="tag"&gt;Pr&#233;vention&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Afrique-subsaharienne-+" rel="tag"&gt;Afrique subsaharienne&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Identites-sexuelles-+" rel="tag"&gt;Identit&#233;s sexuelles&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Recrutement-boules-de-neige-+" rel="tag"&gt;Recrutement &#171;&lt;small class=&#034;fine d-inline&#034;&gt;&#160;&lt;/small&gt;boules de neige&lt;small class=&#034;fine d-inline&#034;&gt;&#160;&lt;/small&gt;&#187;&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Acces-aux-soins-+" rel="tag"&gt;Acc&#232;s aux soins&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Representativite-et-Biais-+" rel="tag"&gt;Repr&#233;sentativit&#233; et Biais&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Epidemiologie-+" rel="tag"&gt;&#201;pid&#233;miologie&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Traitement-antiretroviral-ARV-98-98-+" rel="tag"&gt;Traitement antir&#233;troviral (ARV)&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Depistage-+" rel="tag"&gt;D&#233;pistage&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Prise-en-charge-+" rel="tag"&gt;Prise en charge&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Travail-du-sexe-+" rel="tag"&gt;Travail du sexe&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Treatment-as-Prevention-TasP-105-+" rel="tag"&gt;Treatment as Prevention (TasP)&lt;/a&gt;

		</description>


 <content:encoded>&lt;img src='https://joseph.larmarange.net/local/cache-vignettes/L150xH84/arton230-4237a.jpg?1715174926' class='spip_logo spip_logo_right' width='150' height='84' alt=&#034;&#034; /&gt;
		&lt;div class='rss_chapo'&gt;&lt;p&gt;Communication orale pr&#233;sent&#233;e en session pl&#233;ni&#232;re le 5&#160;avril 2018 lors de la &lt;a href=&#034;http://www.afravih2018.org/&#034; class=&#034;spip_out&#034; rel=&#034;external&#034;&gt;9&lt;sup&gt;e&lt;/sup&gt; conf&#233;rence francophone sur le VIH et les h&#233;patites virales&lt;/a&gt; &#224; Bordeaux.&lt;/p&gt;&lt;/div&gt;
		&lt;div class='rss_texte'&gt;&lt;h2 class=&#034;spip&#034;&gt;
Auteur&lt;/h2&gt;
&lt;p&gt;Joseph Larmarange&lt;/p&gt;
&lt;h2 class=&#034;spip&#034;&gt;
Vid&#233;o&lt;/h2&gt;&lt;iframe width=&#034;100%&#034; height=&#034;400&#034; src=&#034;https://www.youtube-nocookie.com/embed/SdBcT2dPgl4?showinfo=0&amp;start=48&#034; frameborder=&#034;0&#034; allow=&#034;autoplay; encrypted-media&#034; allowfullscreen style=&#034;max-width:100%;&#034;&gt;&lt;/iframe&gt;&lt;dl class='spip_document_238 spip_documents spip_documents_center media media_logo'&gt; &lt;dt&gt;&lt;a href='https://joseph.larmarange.net/IMG/pdf/afravih_2018_pleniere_larmarange.pdf' class=&#034;spip_in&#034; title=&#034;Pr&#233;sentation Pl&#233;ni&#232;re AFRAVIH 2018 (Joseph Larmarange)&#034; hreflang=&#034;&#034; type=&#034;application/pdf&#034;&gt;&lt;img src='https://joseph.larmarange.net/local/cache-vignettes/L64xH64/pdf-b8aed.svg?1772799023' height='64' width='64' alt='Pr&#233;sentation Pl&#233;ni&#232;re AFRAVIH 2018 (Joseph Larmarange)' /&gt;&lt;/a&gt;&lt;/dt&gt; &lt;dt class='spip_doc_titre crayon document-titre-238' style='max-width: 350px;'&gt;&lt;strong&gt;Pr&#233;sentation Pl&#233;ni&#232;re AFRAVIH 2018 (Joseph Larmarange)&lt;/strong&gt;&lt;/dt&gt;&lt;dd class='spip_doc_infos' style='max-width: 350px;'&gt;3.1&#160;Mio&lt;/dd&gt;&lt;/dl&gt;&lt;h2 class=&#034;spip&#034;&gt;
R&#233;f&#233;rence&lt;/h2&gt;
&lt;p&gt;&lt;abbr class=&#034;unapi-id&#034; title=&#034;BEVZD6WQ&#034;&gt;&lt;/abbr&gt;&lt;span class=&#034;csl-bib-body&#034;&gt;&lt;span class=&#034;csl-entry&#034;&gt;&lt;span style=&#034;font-variant: small-caps;&#034;&gt;Larmarange&lt;/span&gt; Joseph (2018) &#171;&#160;D&#233;pister, traiter les populations cach&#233;es&#160;&#187; (communication orale en session pl&#233;ni&#232;re), pr&#233;sent&#233; &#224; &lt;span style=&#034;font-style: italic;&#034; &gt;9e Conf&#233;rence Internationale Francophone sur le VIH et les H&#233;patites Virales (AFRAVIH 2018)&lt;/span&gt;, Bordeaux. https://www.youtube.com/watch?time_continue=48&amp;v=SdBcT2dPgl4.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;
		
		</content:encoded>


		

	</item>
<item xml:lang="en">
		<title>Feasibility and Representativeness of a Random Sample Mobile Phone Survey in C&#244;te d'Ivoire</title>
		<link>https://joseph.larmarange.net/Feasibility-and-Representativeness</link>
		<guid isPermaLink="true">https://joseph.larmarange.net/Feasibility-and-Representativeness</guid>
		<dc:date>2016-07-11T19:33:05Z</dc:date>
		<dc:format>text/html</dc:format>
		<dc:language>en</dc:language>
		<dc:creator>Joseph LARMARANGE</dc:creator>


		<dc:subject>M&#233;thodologie</dc:subject>
		<dc:subject>Mesure des indicateurs</dc:subject>
		<dc:subject>C&#244;te d'Ivoire</dc:subject>
		<dc:subject>Repr&#233;sentativit&#233; et Biais</dc:subject>
		<dc:subject>DOD-CI (ANRS 12287 / 12323)</dc:subject>
		<dc:subject>T&#233;l&#233;phones mobiles</dc:subject>

		<description>
&lt;p&gt;Published in Population in June 2016, Volume 71(1). &lt;br class='autobr' /&gt; Authors &lt;br class='autobr' /&gt;
Joseph Larmarange, Ouattara Kassoum, &#201;lise Kakou, Yves Fradier, Lazare Sika and Christine Danel for the DOD-CI ANRS 12287 Study Group &lt;br class='autobr' /&gt;
Abstract &lt;br class='autobr' /&gt;
This short paper presents the results of an exploratory pilot survey on HIV-AIDS screening (DOD-CI) conducted in C&#244;te d'Ivoire to test the feasibility and representativeness of a national general population survey based on a random sample of mobile phone numbers. The refusal rate was&#160;(&#8230;)&lt;/p&gt;


-
&lt;a href="https://joseph.larmarange.net/-Publications-11-" rel="directory"&gt;Publications&lt;/a&gt;

/ 
&lt;a href="https://joseph.larmarange.net/+-Methodologie-+" rel="tag"&gt;M&#233;thodologie&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Validite-de-la-mesure-+" rel="tag"&gt;Mesure des indicateurs&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Cote-d-Ivoire-+" rel="tag"&gt;C&#244;te d'Ivoire&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Representativite-et-Biais-+" rel="tag"&gt;Repr&#233;sentativit&#233; et Biais&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-DOD-CI-ANRS-12287-+" rel="tag"&gt;DOD-CI (ANRS 12287 / 12323)&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Telephones-mobiles-+" rel="tag"&gt;T&#233;l&#233;phones mobiles&lt;/a&gt;

		</description>


 <content:encoded>&lt;img src='https://joseph.larmarange.net/local/cache-vignettes/L150xH100/arton190-11046.jpg?1715148300' class='spip_logo spip_logo_right' width='150' height='100' alt=&#034;&#034; /&gt;
		&lt;div class='rss_chapo'&gt;&lt;p&gt;Published in &lt;i&gt;Population&lt;/i&gt; in June 2016, Volume 71(1).&lt;/p&gt;&lt;/div&gt;
		&lt;div class='rss_texte'&gt;&lt;h2 class=&#034;spip&#034;&gt;
Authors&lt;/h2&gt;
&lt;p&gt;Joseph Larmarange, Ouattara Kassoum, &#201;lise Kakou, Yves Fradier, Lazare Sika and Christine Danel for the DOD-CI ANRS 12287 Study Group&lt;/p&gt;
&lt;h2 class=&#034;spip&#034;&gt;
Abstract&lt;/h2&gt;
&lt;p&gt;This short paper presents the results of an exploratory pilot survey on HIV-AIDS screening (DOD-CI) conducted in C&#244;te d'Ivoire to test the feasibility and representativeness of a national general population survey based on a random sample of mobile phone numbers. The refusal rate was low, and below the levels habitually observed for similar surveys conducted in France. In terms of representativeness, the sample obtained was younger, more urban and more masculine than the population in general. Four HIV-AIDS screening indicators were compared with those obtained in the Demographic and Health survey (DHS) conducted in 2011-2012. Owing to differences in selection biases affecting the two surveys, the indicators were higher than those observed in the DHS 2011-2012. However, the differences observed by sex, age group, level of education and place of residence were similar. This confirms the feasibility of applying such an approach for a national survey in C&#244;te d'Ivoire, providing that several adjustments are made, such as including non-subscribers living in the same household as a mobile phone subscriber.&lt;/p&gt;
&lt;h2 class=&#034;spip&#034;&gt;
R&#233;f&#233;rence&lt;/h2&gt;
&lt;p&gt;&lt;abbr class=&#034;unapi-id&#034; title=&#034;AH8N7UC2&#034;&gt;&lt;/abbr&gt;&lt;span class=&#034;csl-bib-body&#034;&gt;&lt;span class=&#034;csl-entry&#034;&gt;&lt;span style=&#034;font-variant: small-caps;&#034;&gt;Larmarange&lt;/span&gt; Joseph, &lt;span style=&#034;font-variant: small-caps;&#034;&gt;Kassoum&lt;/span&gt; Ouattara, &lt;span style=&#034;font-variant: small-caps;&#034;&gt;Kakou&lt;/span&gt; &#201;lise, &lt;span style=&#034;font-variant: small-caps;&#034;&gt;Fradier&lt;/span&gt; Yves, &lt;span style=&#034;font-variant: small-caps;&#034;&gt;Sika&lt;/span&gt; Lazare, &lt;span style=&#034;font-variant: small-caps;&#034;&gt;Danel&lt;/span&gt; Christine et &lt;span style=&#034;font-variant: small-caps;&#034;&gt;DOD-CI ANRS 12287 Study Group&lt;/span&gt; (2016) &#171;&#160;Feasibility and Representativeness of a Random Sample Mobile Phone Survey in C&#244;te d'Ivoire&#160;&#187;, &lt;span style=&#034;font-style: italic;&#034; &gt;Population&lt;/span&gt;, Vol. 71 (1) (juillet 1), p.&#160;121-134. DOI&#160;: 10.3917/popu.1601.0121. http://www.cairn.info/resume.php?ID_ARTICLE=E_POPU_1601_0121.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;
		
		</content:encoded>


		

	</item>



</channel>

</rss>
